Leonteq Securities’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding SYRE
Leonteq Securities's SYRE Position: Q3 2026 in Review
Leonteq Securities opened a new position in Spyre Therapeutics (SYRE) in Q3 2026: 101 shares worth $8.99K. The stake represents ﹤0.01% of the portfolio and ranks #1023 among its holdings.
197 funds tracked by Wall St. Rank hold SYRE as of Q3 2026.
- Leonteq Securities held 101 shares of Spyre Therapeutics worth $8.99K as of Q3 2026.
- Spyre Therapeutics was a new Leonteq Securities position in Q3 2026.
- Spyre Therapeutics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1023 holding.
- 197 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.